Effects of Curcumin on Vascular Endothelial Growth Factor Expression on Rattus norvegicus Cervical Cancer Xenograft Model

Laili Muninggar* -  Department of Obstetric and Gynecology, Dr. Soetomo Hospital/Airlangga University, Surabaya,, Indonesia
Widjiati Widjiati -  Department of Embryology, Faculty of Veterinary Medicine, Airlangga University, Surabaya, Indonesia
Indra Yuliati -  Department of Obstetric and Gynecology, Dr. Soetomo Hospital/Airlangga University, Surabaya,, Indonesia
Brahmana Askandar -  Department of Obstetric and Gynecology, Dr. Soetomo Hospital/Airlangga University, Surabaya,, Indonesia
Poedjo Hartono -  Department of Obstetric and Gynecology, Dr. Soetomo Hospital/Airlangga University, Surabaya,

DOI : 10.33371/ijoc.v12i3.616

Objective: To analyze the effect of curcumin in VEGF expression on Rattus norvegicus cervical cancer cell xenograft model.

Methods: An experimental study with randomized post test only control group design. The subjects were Rattus norvegicus (Sprague Dawley), inoculated with He-la cervical cancer cells from American Type Culture Collection (ATCC) processed in stem cell laboratory Institute of Tropical Disease (ITD) Airlangga University. 5x106 of He-La cells were injected subcutaneously in dorsal flank area of Rattus norvegicus. After 30 days of observation we performed histopathological examination of xenograft tissue and randomized into 2 groups which were given curcumin orally 1000 mg/kg (curcumin group) vs. no therapy (control group). After another 30 days the xenograft tissue was dissected and underwent immunochemistry examination for VEGF expression.

Results: 32 samples of Rattus norvegicus were divided into 2 groups, In curcumin group the VEGF median expression was 2,2 (0,3-7,6) and in control group the VEGF median expression was 6,6 (1,2-12). There was a statistically significant difference with p value =0,009 with Mann Whitney test (p<0,05).

Conclusion: VEGF expression in Rattus norvegicus xenograft model of cervical cancer was suppressed by giving Curcumin 1000 mg/kgBB orally.

Keywords
Cervical cancer, Curcumin, VEGF, Xenograft
Full Text:
Article Info
Submitted: 2019-01-01
Published: 2019-01-01
Section: Research Articles
Article Statistics: 39 28